Immuron (IMRN) Return on Assets (2018 - 2025)
Immuron (IMRN) posted quarterly Return on Assets of 5039936256.33% for Q3 2025, up 503993625633.0% year-over-year from N/an in Q3 2024, and up 119.26% quarter-over-quarter from 2298576329.98% in Q2 2025.
Immuron (IMRN) Return on Assets (2018 - 2025) Analysis & Trends
Immuron's Return on Assets history runs 8 years deep, the most recent figure standing at 5039936256.33% for Q3 2025.
- In Q3 2025, Return on Assets rose 503993625633.0% year-over-year to 5039936256.33%; the TTM figure through Sep 2025 stood at 5039936256.33% (up 503993625633.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
- Return on Assets for Q3 2025 stood at 5039936256.33%, up from 2298576329.98% in the prior quarter.
- The five-year high for Return on Assets was 5039936256.33% in Q3 2025, with the low at 0.0% in Q4 2023.
- The 5-year median for Return on Assets is 0.0% (2022), against an average of 1039168135.9%.
- The sharpest annual moves came in 2022 and 2025: Return on Assets changed 0 bps in 2022, then soared 2000000000 bps in 2025.
- Immuron's Return on Assets stood at 0.0% in 2021, then tumbled by 224 bps to 0.0% in 2022, then plunged by 1993 bps to 0.0% in 2023, then soared by 2000000000 bps to 4092336908.65% in 2024, then increased by 23 bps to 5039936256.33% in 2025.
- Business Quant data shows IMRN's Return on Assets at 5039936256.33% in Q3 2025, 2298576329.98% in Q2 2025, and 4092336908.65% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 5,039,936,256.33% |
| Jun 30, 2025 | 2,298,576,329.98% |
| Dec 31, 2024 | 4,092,336,908.65% |
| Sep 9, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Aug 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Jun 30, 2019 | 0.00% |
| Jun 30, 2018 | 0.00% |